Co-Diagnostics (CODX) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to -$11.4 million.
- Co-Diagnostics' Enterprise Value rose 6961.42% to -$11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.4 million, marking a year-over-year increase of 6961.42%. This contributed to the annual value of -$29.7 million for FY2024, which is 4919.14% up from last year.
- As of Q3 2025, Co-Diagnostics' Enterprise Value stood at -$11.4 million, which was up 6961.42% from -$13.4 million recorded in Q2 2025.
- Co-Diagnostics' 5-year Enterprise Value high stood at -$11.4 million for Q3 2025, and its period low was -$98.4 million during Q1 2022.
- Its 5-year average for Enterprise Value is -$60.2 million, with a median of -$63.4 million in 2023.
- Per our database at Business Quant, Co-Diagnostics' Enterprise Value tumbled by 26251.84% in 2021 and then soared by 7022.52% in 2025.
- Co-Diagnostics' Enterprise Value (Quarter) stood at -$89.9 million in 2021, then rose by 9.57% to -$81.3 million in 2022, then increased by 27.95% to -$58.5 million in 2023, then skyrocketed by 49.19% to -$29.7 million in 2024, then soared by 61.53% to -$11.4 million in 2025.
- Its last three reported values are -$11.4 million in Q3 2025, -$13.4 million for Q2 2025, and -$21.5 million during Q1 2025.